Cargando…

Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner

Background  This study was aimed to optimize the fluorodeoxyglucose (FDG)-administered dose and scan time based on patient specifications using a highly sensitive five-ring bismuth germanium oxide (BGO)-based positron emission tomography/computed tomography (PET/CT) scanner (Discovery IQ). Methods  ...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Fatlawi, Murtadha, Pak, Farideh, Farzanefar, Saeed, Salehi, Yalda, Monsef, Abbas, Sheikhzadeh, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581753/
https://www.ncbi.nlm.nih.gov/pubmed/37854082
http://dx.doi.org/10.1055/s-0043-1771284
_version_ 1785122197582381056
author Al-Fatlawi, Murtadha
Pak, Farideh
Farzanefar, Saeed
Salehi, Yalda
Monsef, Abbas
Sheikhzadeh, Peyman
author_facet Al-Fatlawi, Murtadha
Pak, Farideh
Farzanefar, Saeed
Salehi, Yalda
Monsef, Abbas
Sheikhzadeh, Peyman
author_sort Al-Fatlawi, Murtadha
collection PubMed
description Background  This study was aimed to optimize the fluorodeoxyglucose (FDG)-administered dose and scan time based on patient specifications using a highly sensitive five-ring bismuth germanium oxide (BGO)-based positron emission tomography/computed tomography (PET/CT) scanner (Discovery IQ). Methods  We retrospectively analyzed 101 whole-body (18) F-FDG PET/CT images. Patient data were reconstructed using ordered subset expectation maximization with resolution recovery algorithms (OSEM + SharpIR). Signal-to-noise ratio (SNR) was calculated for each patient, standardized to SNR (norm) , and plotted against three body index parameters (weight, body mass index, and lean body mass). Two professional physicians blindly examined image quality at different patient time per bed positions to determine the minimum acceptable quality. To select images of acceptable quality, the noise index parameter was also measured. A new dose-time product (DTP) was established for each patient, and a predicted injected dose was assumed. Results  We found an almost linear association between patient weight and normalized SNR, and patient weight had the highest R (2) in the fitting. The redesigned DTP can reduce results by approximately 74 and 38% compared with ordinary DTP for 80- and 160-s scan durations. The new dose regimen formula was found to be DTP =  c/t × m (1.24) , where m is the patient weight, t is the scan time per bed position, and c is 1.8 and 4.3 for acceptable and higher confidence states, respectively, in Discovery IQ PET/CT. Conclusion  Patient weight is the best clinical parameter for the implementation of (18) F-FDG PET/CT image quality assessment. A new dose-time regimen based on body weight was proposed for use in highly sensitive five-ring BGO PET-CT scanners to significantly reduce the injection dose and scan times while maintaining sufficient image quality for diagnosis.
format Online
Article
Text
id pubmed-10581753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-105817532023-10-18 Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner Al-Fatlawi, Murtadha Pak, Farideh Farzanefar, Saeed Salehi, Yalda Monsef, Abbas Sheikhzadeh, Peyman World J Nucl Med Background  This study was aimed to optimize the fluorodeoxyglucose (FDG)-administered dose and scan time based on patient specifications using a highly sensitive five-ring bismuth germanium oxide (BGO)-based positron emission tomography/computed tomography (PET/CT) scanner (Discovery IQ). Methods  We retrospectively analyzed 101 whole-body (18) F-FDG PET/CT images. Patient data were reconstructed using ordered subset expectation maximization with resolution recovery algorithms (OSEM + SharpIR). Signal-to-noise ratio (SNR) was calculated for each patient, standardized to SNR (norm) , and plotted against three body index parameters (weight, body mass index, and lean body mass). Two professional physicians blindly examined image quality at different patient time per bed positions to determine the minimum acceptable quality. To select images of acceptable quality, the noise index parameter was also measured. A new dose-time product (DTP) was established for each patient, and a predicted injected dose was assumed. Results  We found an almost linear association between patient weight and normalized SNR, and patient weight had the highest R (2) in the fitting. The redesigned DTP can reduce results by approximately 74 and 38% compared with ordinary DTP for 80- and 160-s scan durations. The new dose regimen formula was found to be DTP =  c/t × m (1.24) , where m is the patient weight, t is the scan time per bed position, and c is 1.8 and 4.3 for acceptable and higher confidence states, respectively, in Discovery IQ PET/CT. Conclusion  Patient weight is the best clinical parameter for the implementation of (18) F-FDG PET/CT image quality assessment. A new dose-time regimen based on body weight was proposed for use in highly sensitive five-ring BGO PET-CT scanners to significantly reduce the injection dose and scan times while maintaining sufficient image quality for diagnosis. Thieme Medical and Scientific Publishers Pvt. Ltd. 2023-09-06 /pmc/articles/PMC10581753/ /pubmed/37854082 http://dx.doi.org/10.1055/s-0043-1771284 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Al-Fatlawi, Murtadha
Pak, Farideh
Farzanefar, Saeed
Salehi, Yalda
Monsef, Abbas
Sheikhzadeh, Peyman
Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title_full Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title_fullStr Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title_full_unstemmed Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title_short Optimization of the Acquisition Time and Injected Dose of (18) F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner
title_sort optimization of the acquisition time and injected dose of (18) f-fluorodeoxyglucose based on patient specifications for high-sensitive positron emission tomography/computed tomography scanner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581753/
https://www.ncbi.nlm.nih.gov/pubmed/37854082
http://dx.doi.org/10.1055/s-0043-1771284
work_keys_str_mv AT alfatlawimurtadha optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner
AT pakfarideh optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner
AT farzanefarsaeed optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner
AT salehiyalda optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner
AT monsefabbas optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner
AT sheikhzadehpeyman optimizationoftheacquisitiontimeandinjecteddoseof18ffluorodeoxyglucosebasedonpatientspecificationsforhighsensitivepositronemissiontomographycomputedtomographyscanner